Bone Biologics Corp.
13F holders, Q1 2024 (March 31)4holders
$2.13avg. 13F price*
At the end of Q1 2024, 4 institutions reported holding Bone Biologics Corp. in their 13F filings. The largest holders were Armistice Capital, LLC ($79K), Tower Research Capital LLC (TRC) ($9K) and UBS Group AG ($1K).
- Company
- Bone Biologics Corp.
- CUSIP
- 098070501
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $80K |
| Exits | 0 | $0 |
Ownership 4 holders
| Armistice Capital, LLC | 0.00% | New | 37,000 | $79K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +246.9% | 4,250 | $9K |
| UBS Group AG | 0.00% | New | 600 | $1K |
| Wells Fargo & Company | 0.00% | No change | 4 | $9 |
"% of holder's portfolio" is BONE BIOLOGICS CORP's weight in each manager's 13F, not the share of Bone Biologics Corp. the manager owns.